Italy brings nearly €19B medtech ecosystem to WHX Miami 2026

Italy will send 16 healthcare technology companies to WHX Miami 2026 from June 17-19, using the show to pitch AI diagnostics, telemedicine, radiation-free screening and other tools to U.S. buyers and partners. The delegation arrives as Italy’s medical device sector approaches €19 billion in annual value and seeks to deepen exports to the U.S., its top non-European market. Why it matters: - Italy is using WHX Miami 2026 to push a medtech sector that is large, export-driven and increasingly focused on digital health, early diagnostics and minimally invasive care. - The U.S. matters most outside Europe for Italian medtech, with exports to the market reaching about €860.8 million in 2024. - The delegation gives Italian companies a direct platform to meet U.S. and international distributors, providers, investors and partners across the medical value chain. What happened: - Italy is sending a 16-company medtech delegation to World Health Expo Miami 2026, which runs June 17-19. - The Italian Pavilion is coordinated by the Italian Trade Agency. - The pavilion includes companies and organizations from across Italy, including Farmaflor, Ferrucci Group, HC Italia, Rigenera HBW–Human Brain Wave, Icarus, Infomedix, IngeniArs, Lo.Li. Pharma International, LUMED, Medency, Revée, Rilemo, UBT–Umbria Bioengineering Technologies, the University of Siena, WISE and XCOPE. - WHX Miami, formerly known as FIME, brings together more than 15,000 professionals and 1,300 exhibitors from more than 120 countries. The details: - Italy’s medical device sector was worth nearly €19 billion in 2025, including domestic sales and exports. - The sector included more than 4,600 companies and employed over 130,000 people. - Confindustria Dispositivi Medici data shows the supply chain includes 2,774 manufacturing companies, 1,511 distributors and 363 service providers. - Small and medium-sized enterprises make up about 94% of all companies in the sector. - Italian medical device exports exceed €6 billion a year. - Italy ranks third in Europe by medtech sector size, behind Germany and France. - The Italian Pavilion will showcase technologies for early diagnostics, regenerative medicine, digital health, telemedicine, clinical assistance, surgery, women’s health, neurorehabilitation and business development. - The exhibiting portfolio spans established manufacturers, SMEs, startups, biotech companies, nutraceutical specialists, laser device makers, compression garment manufacturers, rehabilitation technology providers, cardiopulmonary monitoring companies and B2B platforms. - Displayed technologies include AI tools for clinical front desks, CE-marked and FDA-registered telemedicine platforms, portable AI-based neuroimaging for point-of-care cerebral diagnostics, non-ionizing microwave technology for early breast cancer detection, implantable leads for neuromonitoring and neuromodulation, VR-based digital sedation systems, advanced laser systems for ENT, surgery, dentistry and podiatry, and patented micrograft technologies for tissue regeneration. - The pavilion also features safe microwave-based breast cancer screening, portable neuroimaging devices, telemedicine platforms, tissue regeneration technologies and virtual reality-based digital sedation solutions. Between the lines: - Italy is framing medtech as a national industrial strength, not just a healthcare niche, with a broad mix of manufacturers, service firms and research-driven SMEs. - The product mix points to where demand is growing: faster diagnosis, remote care, workflow automation and less invasive treatment. - The presence of FDA-registered and CE-marked products suggests exhibitors are targeting international commercialization, especially in the U.S. market. What’s next: - The Italian companies will use WHX Miami 2026 to build commercial relationships and pursue distribution, investment and partnership opportunities. - The show could become a launch point for U.S. market expansion for exhibitors with already regulated or export-ready technologies. - Italy’s broader medtech sector will likely keep leaning on international trade events as it grows exports and raises its profile outside Europe.